miR-155 mainly functions as an oncomiR by targeting tumor suppressors including SOCS1, tumor protein p53 inducible nuclear protein 1 (TP53INP1), CDC73, von Hippel-Lindau tumor suppressor (VHL), and mutL homolog 1 (MLH1). The gene discussed is MLH1; the disease is neoplasm.